Full-Time

Manager – Cell Therapy Manufacturing

Confirmed live in the last 24 hours

Deadline 7/28/25
Bristol Myers Squibb

Bristol Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

No salary listed

Senior

Company Historically Provides H1B Sponsorship

Devens, MA, USA

Category
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • Bachelors in relevant science or engineering discipline, or equivalent in work experience.
  • 5+ years of experience in cGMP biologics cell culture manufacturing
Responsibilities
  • Manage the creation, implementation and compliance for all documentation, procedures and policies
  • Operate within the requirements of a validated manufacturing systems, plan, assign and oversee daily operational activities associated with assigned areas of responsibility.
  • Maintain operating and storage areas that are compliant, efficient, effective and safe.
  • Identify strategic and operational issues to prevent deviations and maintain a compliant environment. Lead and manage the development of corrective and preventative actions, deviation responses and investigations.
  • Manage implementation and maintenance of appropriate training curricula
  • Create an environment of teamwork, open communication, and a sense of urgency. Foster a culture of safety and compliance that embraces safety in the work environment and the safety of the patients by compliance with company procedures and policies, and cGMP requirements.
  • Efficiently coordinate, communicate, and provide Operations project information and activities status to Planning, Manufacturing, Quality Assurance / Operations, Global Supply and other associated functions in a timely manner in accordance to schedules and defined implementation timelines
  • Oversee operators on daily basis as they: Perform unit operations and support operations described in standard operating procedures and batch records in a safe and GMP compliant manner. Complete documentation required by process transfer protocols, validation protocols, standard operating procedures, and batch records. Maintain training assignments to ensure the necessary technical skills and knowledge. Assist in the setup of manufacturing areas and equipment/fixtures and perform facility and equipment commissioning, qualification and validation activities. Writing manufacturing operating procedures that are technically sound, promote effective and efficient operations, and comply with cGMP requirements
  • Hire, mentor and develop exceptional people: Conduct performance reviews and identify opportunities for career growth for manufacturing associates.
  • This position will require shift work, including holidays and weekends.
  • This position will require you to work in a clean room environment, with exposure to human blood components and in close proximity to strong magnets.
Desired Qualifications
  • Experience in cell therapy manufacturing
  • Aseptic processing in ISO 5 biosafety cabinets and universal precautions for handling human derived materials in BSL-2 containment areas.
  • Cell expansion using incubators and single use bioreactors, Cell washing processes, Cell separation techniques and cryopreservation processes and equipment.

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs that are affordable alternatives to their innovative medicines, ensuring they meet high safety and quality standards. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, along with a strong commitment to sustainability and corporate responsibility. The company's goal is to improve patient outcomes by providing effective and affordable healthcare solutions while adhering to Environmental, Social, and Governance (ESG) principles.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery can reduce time and cost in BMS's drug development.
  • Real-world evidence use can enhance BMS's drug approval process efficiency.
  • Telemedicine expansion offers BMS new opportunities for patient engagement and monitoring.

What critics are saying

  • Layoffs and facility closures may disrupt production and affect employee morale.
  • New leadership may lead to strategic shifts, causing potential instability.
  • $40 billion US investment amidst cost-cutting could strain BMS's financial resources.

What makes Bristol Myers Squibb unique

  • BMS focuses on oncology, immunology, and cardiovascular diseases, setting it apart in biopharma.
  • The company invests heavily in R&D to develop innovative and generic medicines.
  • BMS emphasizes sustainability and ESG goals, enhancing its corporate responsibility image.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Company News

Pipeline Review
May 21st, 2025
Tubulis Achieves Key Milestone in BMS Strategic License Agreement as First Collaboration Tubutecan ADC Enters the Clinic

Under the terms of the original collaboration agreement, Bristol Myers Squibb holds exclusive rights to develop and commercialize selected ADCs using Tubulis' proprietary Tubutecan platform.

BioSpace
May 6th, 2025
BMS Pledges $40B Investment in US Despite Cost-Cutting Plans

This year alone BMS has laid off more than 800 employees, the bulk of which were just revealed this month, putting 516 jobs on the chopping block.

ROI-NJ
May 6th, 2025
Bristol Myers Squibb Names Gallman Executive Vp, General Counsel And Chief Policy Officer

Bristol Myers Squibb, the fourth-largest company in New Jersey by market cap, announced Tuesday the appointment of Cari Gallman as executive vice president, general counsel and chief policy officer, effective immediately. She succeeds Sandra (Sandy) Leung, who is retiring after a 33-year career at the company.Gallman has extensive experience in pharmaceutical law and compliance. She will lead the law department, which includes intellectual property, commercial and regulatory law, litigation, securities and corporate governance, transactions, corporate security and compliance and ethics, as well as global and U.S. policy and government affairs. Gallman has held leadership positions at Bristol Myers Squibb for 10 years, most recently serving as executive vice president, corporate affairs.“I am committed to continuing to build on the company’s culture of integrity and shape a dynamic policy environment that protects innovation and patients,” said Gallman in a statement.Gallman began her legal career in private practice representing pharmaceutical and medical device manufacturers in civil, regulatory, and government enforcement matters.She earned a bachelor’s degree in political theory from Princeton University, magna cum laude, and holds a juris doctor degree from Harvard Law School

Endpoints News
May 5th, 2025
Bristol Myers to lay off over 500 workers in New Jersey

Bristol Myers to lay off over 500 workers in New Jersey.

NJBIZ
May 5th, 2025
Bristol Myers Squibb plans 500+ layoffs in NJ

BMS recently announced plans to close a manufacturing facility in Illinois that handles viral vector production.